Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19

AIMS: We examined the value of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in patients admitted for coronavirus disease 2019 (COVID‐19) without prior history of heart failure (HF) or cardiomyopathy. METHODS AND RESULTS: Retrospective cohort of consecutive adults (N = 679; median age 59 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jeanwoo, Grewal, Prabhjot, Hotelling, Jessica, Papamanoli, Aikaterini, Cao, Kerry, Dhaliwal, Simrat, Jacob, Robin, Mojahedi, Azad, Bloom, Michelle E., Marcos, Luis A., Skopicki, Hal A., Kalogeropoulos, Andreas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426942/
https://www.ncbi.nlm.nih.gov/pubmed/34346182
http://dx.doi.org/10.1002/ehf2.13548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426942/
https://www.ncbi.nlm.nih.gov/pubmed/34346182
http://dx.doi.org/10.1002/ehf2.13548

Ejemplares similares